AIM ImmunoTech Inc.
AIM ImmunoTech Inc. (AIM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AIM · as of Jun 8, 2026
Key Statistics
Explore AIM ImmunoTech Inc. Data
aim stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
aim competitorsAIM
CANF
ENSC
KALA
KTTA
OGENStock Performance
Full HistoryAbout AIM ImmunoTech Inc.
AIM ImmunoTech Inc. an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United…
what is aim immunotech inc. · aim stock overview · aim immunotech inc. company profile · who is aim immunotech inc. ceo · aim AMEX · aim immunotech inc. headquarters · aim immunotech inc. business segments
About Stock Overview & Key Data
AIM ImmunoTech Inc. (AIM) is a Healthcare company in the Biotechnology industry, listed on AMEX since Nov 2, 1995. As of the latest trading session, AIM stock price is $0.52, with a market capitalization of $1.8M. The stock has returned -92.06% over the past 12 months and -53.72% year-to-date.
According to 3 Wall Street analysts, the consensus rating for AIM ImmunoTech Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, AIM ImmunoTech Inc. reported revenue of $88000.00 and net income of -$14.0M. For detailed data — including AIM ImmunoTech Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AIM ImmunoTech Inc. (AIM) stock price is $0.52. The stock is traded on AMEX under the ticker symbol AIM. The 52-week range is $0.21 – $19.74.